Skip to Main Content

Search

Home
Find Activities
We Asked, You Said, We Did

Consultation on applications for authorisation of regulated products: Three CBD products as novel foods

Page 1 of 3

Closes 16 Jun 2026

This service needs cookies enabled.

Consultation Questions covering all four applications

Thank you for taking the time to read our consultation document. We would now be grateful if you could answer the following questions:

1. Please note that Food Standards Scotland may publish details that you supply in legitimate pursuit of the functions of the organisation. Do you agree to the publication of your personal details and response?

(Required) Yes, all of my response and name/organisation can be published. Yes, but only my response can be published, not my name/organisation. No, name/organisation and response both should not be published.

2. What is your name?

Insert your name here (Required)

3. What is your email address? If you enter your email address then you will automatically receive an acknowledgement email when you submit your response.

Your email address

4. Are you responding as a private individual or on behalf of an organisation/company?

(Required) As a private individual On behalf of an organisation/company

5. Please provide the name, phone number and address of your organisation

Your organisational details (Required)

6. Do you consider the labelling provisions with respect to the ADI to be sufficient to help consumers make safe choices when consuming multiple CBD products in a day?

(Required) Yes No

Please write your response here:

7. Do you consider the labelling proposals included in the draft risk management recommendations to be sufficient to mitigate against consumption by under 18s?

(Required) Yes No

Please write your response here:

8. Do you have any other comments about our approach to use labelling for the protection of vulnerable groups, or any of the specific labelling proposals for individual applications?

Yes No

Please write your response here:

9. Do you have any concerns about the safety of the CBD products with respect to the intended consumers?

Yes No

Please write your response here:

10. Do you have any comments on the impacts, if any, resulting from the legal status of CBD products authorised to contain trace amounts of THC and resulting complications, if any, relating to enforcement under drugs legislation or the Novel Food Regulations?

Yes No

Please write your response here:

11. Are there any other impacts on enforcement you wish to make the FSS aware of?

Yes No

Please write your response here:

12. Do you have any comments about how the data protection provisions in the draft risk management recommendations may impact CBD products, the CBD industry as a whole, or the enforcement of CBD products?

Yes No

Please write your response here:

13. Should the CBD products be authorised, what impacts, if any, are there on consumers or businesses in relation to the marketing of CBD products?

Yes No

Please write your response here:

14. Do you have any comments or concerns on the impacts of authorising or not authorising the CBD products? If in favour of authorisation, do you have any points about the terms on which the CBD products are authorised (outlined in the FSS risk management recommendations)?

Yes No

Please write your response here:

15. Are there any other legitimate factors that should be considered by ministers that have not already been highlighted?

Yes No

Please write your response here:

16. Do you have any other feedback on the information presented in the consultation, or on anything that has not been covered?

Yes No

Please write your response here:

Accessibility
Terms of Use
Cookies
Privacy
Help / feedback

Citizen Space from Delib